Baxter International Inc. (NYSE:BAX) Shareholders to Get $0.01 Quarterly Dividend

Baxter International Inc. (NYSE:BAX) declared a quarterly dividend on Wednesday, October 28th. Shareholders of record on Friday, November 27th will be paid a dividend of $0.01 per share by the medical instruments supplier on Monday, January 4th. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, November 27th.

Baxter International has decreased its dividend payment by an average of 0.1% per year over the last three years. Baxter International has a dividend payout ratio of 1.5% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Baxter International to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.

Baxter International Trading Down 7.8%

Shares of NYSE:BAX opened at $23.48 on Friday. The company has a market capitalization of $12.14 billion, a PE ratio of -11.34, a P/E/G ratio of 3.85 and a beta of 0.65. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. The business’s fifty day simple moving average is $24.65 and its 200-day simple moving average is $21.35. Baxter International has a 12-month low of $15.73 and a 12-month high of $30.00.

Baxter International (NYSE:BAX) last issued its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 EPS for the quarter, beating the consensus estimate of $0.52 by $0.06. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The firm had revenue of $2.98 billion during the quarter, compared to analyst estimates of $2.91 billion. During the same quarter in the prior year, the business posted $0.69 EPS. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. As a group, equities research analysts predict that Baxter International will post 2.04 earnings per share for the current fiscal year.

Baxter International News Summary

Here are the key news stories impacting Baxter International this week:

• Positive Sentiment: Baxter reported third-quarter earnings of $0.58 per share, ahead of the $0.52 consensus estimate, while revenue increased 5% year over year to $2.98 billion and surpassed expectations. The company cited broad-based growth across its business. Baxter Q3 Earnings Beat on Broad-Based Growth, 2026 Outlook Raised
• Positive Sentiment: Management raised its full-year 2026 earnings outlook, signaling confidence in demand and the company’s operating performance. Baxter Raises 2026 Earnings Guidance
• Neutral Sentiment: Baxter declared a quarterly cash dividend of $0.01 per share, payable January 4 to shareholders of record November 27. The annualized yield is approximately 0.2%, making the payout a limited factor for income-focused investors. Baxter Third-Quarter Results and Dividend Announcement
• Negative Sentiment: Third-quarter EPS declined from $0.69 a year earlier to $0.58, and the company continues to face margin pressure. Its negative net margin adds to concerns about the quality and sustainability of earnings growth. Baxter Third-Quarter Earnings and Revenue Results
• Negative Sentiment: Baxter received an FDA warning letter concerning current Good Manufacturing Practice violations. The regulatory action raises potential compliance, remediation, cost and operational risks for investors. Baxter Received FDA Warning Letter Over CGMP Violations

About Baxter International

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.